Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy
Author:
Funder
National Institutes of Health
Alfred Taubman Scholarship
Publisher
Elsevier BV
Subject
Cancer Research
Reference39 articles.
1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001
2. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy;Raymond;Drugs,2000
3. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010
4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
5. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents;Kohl;J Cell Biochem Suppl,1995
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma;Journal of Cancer Research and Clinical Oncology;2024-04-15
2. Ferroptosis in liver cancer: a key role of post-translational modifications;Frontiers in Immunology;2024-04-08
3. The role of long noncoding RNAs in liquid–liquid phase separation;Cellular Signalling;2023-11
4. EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML;International Journal of Molecular Sciences;2022-03-22
5. Post-translational modifications in tumor-associated carbonic anhydrases;Amino Acids;2021-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3